vs
Side-by-side financial comparison of ASTRAZENECA PLC (AZN) and PayPal (PYPL). Click either name above to swap in a different company.
ASTRAZENECA PLC is the larger business by last-quarter revenue ($14.5B vs $8.7B, roughly 1.7× PayPal). ASTRAZENECA PLC runs the higher net margin — 16.9% vs 16.6%, a 0.4% gap on every dollar of revenue. On growth, ASTRAZENECA PLC posted the faster year-over-year revenue change (11.7% vs 3.7%).
AstraZeneca plc (AZ) is a Swedish-British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, UK. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
PayPalPYPLEarnings & Financial Report
PayPal Holdings, Inc. is an American multinational financial technology company operating an online payments system in the majority of countries that support online money transfers; it serves as an electronic alternative to traditional paper methods such as checks and money orders. The company operates as a payment processor for online vendors, auction sites and many other commercial and company users.
AZN vs PYPL — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $14.5B | $8.7B |
| Net Profit | $2.4B | $1.4B |
| Gross Margin | 82.9% | — |
| Operating Margin | 24.3% | 17.4% |
| Net Margin | 16.9% | 16.6% |
| Revenue YoY | 11.7% | 3.7% |
| Net Profit YoY | 27.0% | 28.2% |
| EPS (diluted) | $1.57 | $1.53 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $8.7B | ||
| Q3 25 | — | $8.4B | ||
| Q2 25 | $14.5B | $8.3B | ||
| Q1 25 | — | $7.8B | ||
| Q4 24 | — | $8.4B | ||
| Q3 24 | — | $7.8B | ||
| Q2 24 | $12.9B | $7.9B | ||
| Q1 24 | — | $7.7B |
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | $2.4B | $1.3B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.0B | ||
| Q2 24 | $1.9B | $1.1B | ||
| Q1 24 | — | $888.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 82.9% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 83.1% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 17.4% | ||
| Q3 25 | — | 18.1% | ||
| Q2 25 | 24.3% | 18.1% | ||
| Q1 25 | — | 19.6% | ||
| Q4 24 | — | 17.2% | ||
| Q3 24 | — | 17.7% | ||
| Q2 24 | 21.2% | 16.8% | ||
| Q1 24 | — | 15.2% |
| Q4 25 | — | 16.6% | ||
| Q3 25 | — | 14.8% | ||
| Q2 25 | 16.9% | 15.2% | ||
| Q1 25 | — | 16.5% | ||
| Q4 24 | — | 13.4% | ||
| Q3 24 | — | 12.9% | ||
| Q2 24 | 14.9% | 14.3% | ||
| Q1 24 | — | 11.5% |
| Q4 25 | — | $1.53 | ||
| Q3 25 | — | $1.30 | ||
| Q2 25 | $1.57 | $1.29 | ||
| Q1 25 | — | $1.29 | ||
| Q4 24 | — | $1.09 | ||
| Q3 24 | — | $0.99 | ||
| Q2 24 | $1.24 | $1.08 | ||
| Q1 24 | — | $0.83 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.1B | $10.4B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $44.8B | $20.3B |
| Total Assets | $112.4B | $80.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $10.4B | ||
| Q3 25 | — | $10.8B | ||
| Q2 25 | $7.1B | $10.0B | ||
| Q1 25 | — | $11.2B | ||
| Q4 24 | — | $10.8B | ||
| Q3 24 | — | $11.9B | ||
| Q2 24 | $6.9B | $13.6B | ||
| Q1 24 | — | $14.3B |
| Q4 25 | — | $20.3B | ||
| Q3 25 | — | $20.2B | ||
| Q2 25 | $44.8B | $20.2B | ||
| Q1 25 | — | $20.3B | ||
| Q4 24 | — | $20.4B | ||
| Q3 24 | — | $20.2B | ||
| Q2 24 | $39.6B | $20.6B | ||
| Q1 24 | — | $20.7B |
| Q4 25 | — | $80.2B | ||
| Q3 25 | — | $79.8B | ||
| Q2 25 | $112.4B | $79.8B | ||
| Q1 25 | — | $81.3B | ||
| Q4 24 | — | $81.6B | ||
| Q3 24 | — | $83.5B | ||
| Q2 24 | $104.3B | $84.0B | ||
| Q1 24 | — | $83.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $2.4B |
| Free Cash FlowOCF − Capex | — | $2.2B |
| FCF MarginFCF / Revenue | — | 25.2% |
| Capex IntensityCapex / Revenue | — | 2.2% |
| Cash ConversionOCF / Net Profit | — | 1.66× |
| TTM Free Cash FlowTrailing 4 quarters | — | $5.6B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $2.4B | ||
| Q3 25 | — | $2.0B | ||
| Q2 25 | — | $898.0M | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | — | $2.4B | ||
| Q3 24 | — | $1.6B | ||
| Q2 24 | — | $1.5B | ||
| Q1 24 | — | $1.9B |
| Q4 25 | — | $2.2B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | — | $692.0M | ||
| Q1 25 | — | $964.0M | ||
| Q4 24 | — | $2.2B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | — | $1.4B | ||
| Q1 24 | — | $1.8B |
| Q4 25 | — | 25.2% | ||
| Q3 25 | — | 20.4% | ||
| Q2 25 | — | 8.3% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | — | 26.2% | ||
| Q3 24 | — | 18.4% | ||
| Q2 24 | — | 17.3% | ||
| Q1 24 | — | 22.9% |
| Q4 25 | — | 2.2% | ||
| Q3 25 | — | 3.0% | ||
| Q2 25 | — | 2.5% | ||
| Q1 25 | — | 2.5% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | — | 2.2% | ||
| Q2 24 | — | 2.0% | ||
| Q1 24 | — | 2.0% |
| Q4 25 | — | 1.66× | ||
| Q3 25 | — | 1.58× | ||
| Q2 25 | — | 0.71× | ||
| Q1 25 | — | 0.90× | ||
| Q4 24 | — | 2.14× | ||
| Q3 24 | — | 1.60× | ||
| Q2 24 | — | 1.35× | ||
| Q1 24 | — | 2.16× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AZN
Segment breakdown not available.
PYPL
| US | $4.9B | 57% |
| Non Us | $3.7B | 43% |
